FilingSEC EDGAR8-K
Alaunos Therapeutics Amends Bylaws to Reduce Quorum Requirement
· SEC accepted
StageBylaw amendment
Filing content
The company amended its bylaws to reduce the quorum requirement for stockholder meetings from a majority to one-third of outstanding shares, effective immediately.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…